Pneumocandin D(0) (CAS 144087-99-0): Quality Intermediate for Antifungal Drug Discovery
The continuous fight against fungal infections necessitates the development of new and effective antifungal agents. Central to this endeavor is the availability of high-quality pharmaceutical intermediates, such as Pneumocandin D(0) (CAS 144087-99-0). This compound plays a vital role as a precursor in the synthesis of a class of drugs known as echinocandins, which are critical in treating invasive candidiasis and aspergillosis. For R&D scientists and procurement specialists, understanding the chemical properties and sourcing reliable Pneumocandin D(0) is a key strategic advantage.
Pneumocandin D(0) functions by inhibiting the fungal enzyme 1,3-β-D-glucan synthase, which is essential for building the fungal cell wall. This specific mechanism of action provides a targeted approach to antifungal therapy, often with a favorable safety profile in humans due to the absence of glucan in mammalian cells. The molecular formula C50H80N8O18 and molecular weight of 1081.213 highlight its complexity and the precision required in its manufacturing process. When you need to buy this intermediate, ensuring a high level of purity is non-negotiable for its intended applications.
As a dedicated supplier and manufacturer of pharmaceutical materials, we provide Pneumocandin D(0) that meets the exacting standards of the biopharmaceutical industry. Our manufacturing processes are optimized for yield and purity, ensuring that our clients receive a product that contributes positively to their synthesis yields and final drug product quality. We understand that consistent supply and competitive price points are critical for our customers’ operations, and we are committed to meeting these demands. Our base in China allows us to leverage efficient production capabilities, making us a strong partner for your procurement needs.
Engaging with a reputable supplier for Pneumocandin D(0) means gaining access to technical expertise and a stable supply chain. We are equipped to handle orders of various scales, supporting both laboratory research and larger-scale production. If your work involves antifungal drug discovery or the development of novel therapeutics that target fungal cell walls, Pneumocandin D(0) is an intermediate you should consider. We encourage you to contact us to discuss your specific requirements and to learn more about how we can support your next project. Discover the difference quality sourcing makes when you purchase Pneumocandin D(0) from us.
Perspectives & Insights
Logic Thinker AI
“We encourage you to contact us to discuss your specific requirements and to learn more about how we can support your next project.”
Molecule Spark 2025
“Discover the difference quality sourcing makes when you purchase Pneumocandin D(0) from us.”
Alpha Pioneer 01
“The continuous fight against fungal infections necessitates the development of new and effective antifungal agents.”